Navigation Links
Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
Date:5/6/2008

candidates may have unanticipated adverse side effects or inadequate therapeutic efficacy; Cadence may experience delays and increased costs with respect to completion of pre-commercialization manufacturing development activities, and may be required to perform additional pre-clinical or clinical testing as a result of changes to manufacturing processes for its product candidates; the company may require substantial additional funding to complete its clinical development programs and successfully launch its products, and it may not be able to raise sufficient capital when needed, or at all; and other risks detailed in Cadence's prior press releases as well as in Cadence's periodic public filings with the Securities and Exchange Commission.

You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Cadence undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Cadence(TM), Acetavance(TM) and Omigard(TM) are trademarks of Cadence Pharmaceuticals, Inc.

Contacts: William R. LaRue

SVP & Chief Financial Officer

Cadence Pharmaceuticals, Inc.

858-436-1400

Anna Gralinska

Director, Investor Relations

Cadence Pharmaceuticals, Inc.

858-436-1452

CADENCE PHARMACEUTICALS, INC.

(a development stage company)

CONDENSED STATEMENTS OF OPERATIONS

(unaudited)

Three Months Ended

March
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
3. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
4. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
5. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
6. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
7. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
8. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
9. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
10. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
11. Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase 2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015  Oticon, Inc. is now accepting nominations for ... awards program, now in its 17 th year, ... demonstrate that hearing loss does not limit a person,s ... People with any degree of hearing loss – from ... four categories earn cash prizes, donations to their favorite ...
(Date:5/28/2015)... ALBANY, N.Y. , May 28, 2015 /PRNewswire/ ... "503B Outsourcing Facility" under section 503B of the ... for this title, the company is subject to ... oversight, producing bulk medications according to the highest ... 21 CFR Part 211. To continuously comply with ...
(Date:5/28/2015)... VIEW, Calif. , May 28, 2015 /PRNewswire/ ... informatics market, Frost & Sullivan recognizes Lexmark ... & Sullivan Award for Company of the Year ... to take HCM to the next level of ... strategic acquisitions and followed them up with large-scale ...
Breaking Medicine Technology:2015 Oticon Focus on People Awards Seek Outstanding People with Hearing Loss For National Recognition and Prizes 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 2Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 3Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 4Frost & Sullivan Acknowledges Lexmark Healthcare's Energy, Creativity, and Diligence in Developing the Leading Next-Generation Healthcare Content Management Platform 5
... LAKE FOREST, Ill., March 5, 2012  RoundTable Healthcare ... exclusively on the healthcare industry, announced today that ... the newly formed RoundTable III Platform Development Corporation ... Mr. Davies will focus his attention on the ...
... 5, 2012   Synteract , Inc., a full-service contract research ... as senior vice president of sales and marketing and has ... global project management, to support growth in the company and ... COO Stewart Bieler, and CFO Patrik Jeanmonod on the executive ...
Cached Medicine Technology:RoundTable Healthcare Partners Names Kent J. Davies CEO of Newly Formed Platform Development Corporation 2Synteract Expands Executive Roles to Support Growth 2Synteract Expands Executive Roles to Support Growth 3
(Date:5/28/2015)... Vancouver, BC (PRWEB) May 28, 2015 ... iData Research ( http://www.idataresearch.com ), the shoulder reconstruction ... the orthopedic small bone & joint market in ... of shoulder arthroplasty procedures in the U.S. due ... as improved device technology resulting in greater patient ...
(Date:5/28/2015)... Houston, Tx (PRWEB) May 28, 2015 ... and decision support company, announces that it will ... and pharmacogenomics (PGx) testing at the annual American ... weekend. , Next-generation sequencing evaluates the DNA in ... The DNA is analyzed for key changes or ...
(Date:5/28/2015)... Hexagon Geospatial is pleased to announce that ... spatial data and mapping services, is using Hexagon Geospatial ... for urban change assessments in Bernalillo County, New Mexico. ... Data Division implemented a countywide approach to generating pixel-resolution ... a variety of different digital aerial camera systems, BHI ...
(Date:5/28/2015)... May 28, 2015 Optimity Advisors ... implementing innovative models of care for healthcare organizations ... alternative reimbursements and help operationalize contracting and engagement ... unveils a bi-weekly series of seven “ OrangePapers” ... Based Contracting. Optimity is a strategy, operations and ...
(Date:5/28/2015)... Sacramento, PA (PRWEB) May 28, 2015 ... wishes and adventures. Each item on the ... absolutely impossible events, experiences and tasks that the owner ... is no right or wrong when it comes to ... starting a business, writing poems, publishing a book, seeing ...
Breaking Medicine News(10 mins):Health News:DePuy Synthes and Biomet Lead Fastest Growing U.S. Shoulder Reconstruction Device Market 2Health News:DePuy Synthes and Biomet Lead Fastest Growing U.S. Shoulder Reconstruction Device Market 3Health News:CompanionDx® Launches Integrated Genomic Solution at ASCO Meeting 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 3Health News:Optimity Advisors Now Offers Outcomes Based Contracting Services to Support Engagement Model For New Healthcare Innovative Models of Care 2
... February 22, 2011 The McKesson Foundation today ... grants as part of its Mobilizing for Healthsm initiative ... diseases through the use of mobile-phone technology. The Mobilizing ... support studies on diabetes care and management at six ...
... February 21, 2011 New research shows that ... and stroke risks may not have gotten approval from ... effects of fluid retention had been better understood. Fluid ... and strokes of medications such as Vioxx, Bextra, and ...
... using a convenient blood glucose test for diagnosing diabetes and ... Mott Children,s Hospital shows it,s not the best way to ... has become the preferred way to diagnose diabetes among the ... The simple test measures longer-term blood sugar levels -- without ...
... French . An electronic health record system ... more must be done to speed up the implementation of this ... in place effectively, doctors and front line health care workers and ... are the findings of an innovative new study assessing the effectiveness ...
... , TUESDAY, Feb. 22 (HealthDay News) -- People with ... others to develop shingles, according to a new study. ... in a painful rash with lesions. Though it was ... an increased risk for the condition, the researchers of the ...
... , TUESDAY, Feb. 22 (HealthDay News) -- Ignition devices ... the number of new arrests of drivers who were ... The team with the U.S. Centers for Disease Control ... ignition interlocks, devices that prevent someone from operating a ...
Cached Medicine News:Health News:McKesson Foundation awards $1.3 million in 6 Mobilizing for Health Research grants 2Health News:New hypothesis explains why drugs increase risk of heart attacks and strokes 2Health News:New hypothesis explains why drugs increase risk of heart attacks and strokes 3Health News:New hypothesis explains why drugs increase risk of heart attacks and strokes 4Health News:Convenient blood test not as effective for diagnosing diabetes in children 2Health News:E-health must be a priority, researchers say 2Health News:Car Ignition 'Interlocks' Thwart Alcohol-Impaired Drivers 2
Puntenney curved forceps, curved, smooth 10 mm platforms....
Nordan tying forceps, straight, titanium, 6.5 mm tying platforms....
Curved, very delicate, smooth jaws with platforms., ,Straight, very delicate, smooth jaws with platforms....
Harms-Tuebingen tying forceps, straight, 6 mm tying platforms....
Medicine Products: